Table 1c.
Publication | Other operations in conjunction with BET | Operations during follow-up | Corticosteroids pre/postop | Other instructions or medication | Complications |
---|---|---|---|---|---|
Silvola et al., 2014 [8] | No TM perforation or grommet → tympanostomy | Valsalva positive at 1 month → grommet removal 1 pt unable to do Valsalva → revision BET 3 pt BET to contralateral side 4 pt did not improve → technetium scintigraphy and for 3 of them explorative tympanotomy and middle ear endoscopy (one had carotid dehiscence and received no further operations) |
Nasal corticosteroid for min 1 month preoperatively and 1 month postoperatively | Valsalva 2 times/day; if Valsalva negative at 1 week, Politzer maneuver → some could perform Valsalva after that | NR |
Schröder et al., 2015 [10] | No | Revision BET to 68/622 pt marked as lost to follow-up for the first operation at the time of revision | Nasal corticosteroid for 6 weeks postop | NR | Emphysema in the parotid region (0.3%), minor bleeding, temporary increase of tinnitus, all resolved with time; insertion of balloon catheter unsuccessful in 3 pt (4 ears) |
Dalchow et al., 2016 [9] | Tympanoplasty to 124/342 pt before or in conjunction with BET | Revision BET to 38/342 pt | 250 mg prednisolone on day 1 postoperatively | Cefuroxime 500 mg ×2 for 5 days postoperatively | No |
Xiong et al., 2016 [11] | NR | NR | Nasal corticosteroid, minimum 6 months preoperatively | NR | No |
Leichtle et al., 2017 [2] | BET+tympanocenthesis (24 cases), tympanoplasty type I (5 cases), tympanoplasty type III (3 cases) | Revision BET (2 cases) | NR | Instructions and motivation for Valsalva and/or Politzer at every visit | Hemotympanum (7%) resolved with time, minor nasal bleeding (21%) resolved with intranasal xylometazoline |
BET, balloon Eustachian tuboplasty; NR, not reported; pt, patient(s); TM, tympanic membrane